<Disease><Name>VERY-LONG-CHAIN ACYL CoA DEHYDROGENASE DEFICIENCY (VLCAD)</Name><Synonym>VLCAD DEFICIENCY; ACADVLD</Synonym><OMIM><Number>201475</Number><URL>http://omim.org/entry/201475</URL></OMIM><Orphanet><Number>26793</Number><URL>http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&amp;Expert=26793</URL></Orphanet><Protein><Number>Very long-chain specific acyl-CoA dehydrogenase, mitochondrial, Long-chain specific acyl-CoA dehydrogenase, mitochondrial</Number><URL>http://www.uniprot.org/uniprot/?query=database:(type:mim%20201475)&amp;sort=score</URL></Protein><ExPASy><Number /><URL /></ExPASy><Gene>17p13.1</Gene><ICD>E71.3</ICD><Summary>rare (1:85000);autosomal recessive ;3 phenotypes: ;- severe form (early death, hypertrophic cardiomyopathy, early onset) ;- milder form with late onset (hypoketotic hypoglycemia, no cardiac involvement) ;- later occurrences in adolescents and adults (rhabdomyolysis, myoglobinuria );Newborn screening for VLCADD suffers from a high false positive rate due to ;false positive results in many heterozygotes and to elevated acylcarnitines ;including C14:1 in some catabolic neonates even in the absence of ACADVL mutations [Simon EO2017]</Summary><Symptoms><symtomp><id>2420</id><symptom>cardiac arrest</symptom><category>CARDIOVASCULAR SYSTEM</category></symtomp><symtomp><id>1877</id><symptom>cardiomegaly</symptom><category>CARDIOVASCULAR SYSTEM</category></symtomp><symtomp><id>2104</id><symptom>cardiomyopathy</symptom><category>CARDIOVASCULAR SYSTEM</category></symtomp><symtomp><id>3677</id><symptom>cardiomyopathy, hypertrophic</symptom><category>CARDIOVASCULAR SYSTEM</category></symtomp><symtomp><id>3679</id><symptom>cardiomyopathy, mixed type / cardiomyopathy</symptom><category>CARDIOVASCULAR SYSTEM</category></symtomp><symtomp><id>1923</id><symptom>coma</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2423</id><symptom>early death</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2105</id><symptom>encephalopathy</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1994</id><symptom>hepatomegaly (large liver)</symptom><category>GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>3195</id><symptom>hypoglycemia</symptom><category>LABORATORY FINDINGS</category></symtomp><symtomp><id>1897</id><symptom>hypotonia</symptom><category>MUSCLES | NERVOUS SYSTEM</category></symtomp><symtomp><id>3198</id><symptom>ketosis, ketoacidosis</symptom><category>LABORATORY FINDINGS</category></symtomp><symtomp><id>1953</id><symptom>lethargy, drowsiness, apathy</symptom><category>NERVOUS SYSTEM | NERVOUS SYSTEM</category></symtomp><symtomp><id>1998</id><symptom>liver involvement or dysfunction</symptom><category>GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>2065</id><symptom>metabolic acidosis</symptom><category>LABORATORY FINDINGS</category></symtomp><symtomp><id>1787</id><symptom>muscle weakness</symptom><category>MUSCLES</category></symtomp><symtomp><id>4098</id><symptom>myoglobinuria</symptom><category /></symtomp><symtomp><id>1786</id><symptom>myopathy</symptom><category>MUSCLES</category></symtomp><symtomp><id>1915</id><symptom>onset, adulthood / adoulthood</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2507</id><symptom>onset, childhood / childhood</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2505</id><symptom>onset, infancy / infancy</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2504</id><symptom>onset, neonatal / neonatal</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2029</id><symptom>pain, muscle / myalgia, pain muscle</symptom><category>GENERAL TOPICS | MUSCLES</category></symtomp><symtomp><id>2482</id><symptom>pericardial effusion</symptom><category>CARDIOVASCULAR SYSTEM</category></symtomp><symtomp><id>2143</id><symptom>respiratory insufficiency / respiratory failure</symptom><category>LUNG OR RESPIRATORY SYSTEM</category></symtomp><symtomp><id>3202</id><symptom>rhabdomyolysis</symptom><category>MUSCLES</category></symtomp><symtomp><id>2337</id><symptom>steatorrhea</symptom><category>GASTROINTESTINAL SYSTEM</category></symtomp></Symptoms><Metabolites><metabolite><id>1593</id><name>Adipic acid</name><specimen>urine</specimen><value>increased</value><min>1.60</min><max>14.30</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method /><comment /></metabolite><metabolite><id>1639</id><name>L-Carnitine</name><specimen>urine</specimen><value>increased</value><min>0.70</min><max>16.40</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>NMR</method><comment>The Human Urine Metabolome</comment></metabolite><metabolite><id>1687</id><name>Suberic acid</name><specimen>urine</specimen><value>normal/inc</value><min>0.90</min><max>2.40</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>NMR</method><comment>The Human Urine Metabolome</comment></metabolite><metabolite><id>2127</id><name>Myoglobin</name><specimen>urine</specimen><value>increased</value><min>10.00</min><max>65.00</max><unit>ng/ml</unit><age>ALL</age><method /><comment /></metabolite><metabolite><id>99</id><name>Adipic acid</name><specimen>urine</specimen><value>increased</value><min>1.00</min><max>7.00</max><unit>mmol/mol creatinine</unit><age>adolescence</age><method /><comment /></metabolite><metabolite><id>555</id><name>Adipic acid</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>20.00</max><unit>mmol/mol creatinine</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>556</id><name>Adipic acid</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>15.00</max><unit>mmol/mol creatinine</unit><age>infancy</age><method /><comment /></metabolite><metabolite><id>558</id><name>Adipic acid</name><specimen>urine</specimen><value>increased</value><min>2.00</min><max>10.00</max><unit>mmol/mol creatinine</unit><age>childhood</age><method /><comment /></metabolite><metabolite><id>1441</id><name>Adipic acid</name><specimen>urine</specimen><value>increased</value><min>74.00</min><max>610.00</max><unit>mmol/mol creatinine</unit><age>ALL</age><method /><comment /></metabolite><metabolite><id>2008</id><name>Adipic acid</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>0.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment>Bruker 2018</comment></metabolite><metabolite><id>270</id><name>L-Carnitine</name><specimen>urine</specimen><value>increased</value><min>8.00</min><max>21.00</max><unit>mmol/mol creatinine</unit><age>child</age><method /><comment /></metabolite><metabolite><id>272</id><name>L-Carnitine</name><specimen>urine</specimen><value>increased</value><min>0.60</min><max>15.40</max><unit>mmol/mol creatinine</unit><age>adult</age><method /><comment /></metabolite><metabolite><id>1214</id><name>L-Carnitine</name><specimen>blood</specimen><value>increased</value><min>6.83</min><max>43.45</max><unit>&#181;mol/l</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>1215</id><name>L-Carnitine</name><specimen>plasma</specimen><value>normal decreased</value><min>11.61</min><max>73.87</max><unit>&#181;mol/l</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>59</id><name>L-Carnitine</name><specimen>plasma</specimen><value>normal decreased</value><min>23.00</min><max>60.00</max><unit>&#181;mol/l</unit><age>child</age><method /><comment /></metabolite><metabolite><id>268</id><name>L-Carnitine</name><specimen>plasma</specimen><value>normal decreased</value><min>35.00</min><max>55.00</max><unit>&#181;mol/l</unit><age>adult</age><method /><comment /></metabolite><metabolite><id>1090</id><name>L-Carnitine</name><specimen>plasma</specimen><value>normal decreased</value><min>20.00</min><max>40.00</max><unit>&#181;mol/l</unit><age>child</age><method /><comment /></metabolite><metabolite><id>1163</id><name>L-Carnitine</name><specimen>plasma</specimen><value>normal decreased</value><min>15.00</min><max>40.00</max><unit>&#181;mol/l</unit><age>infant</age><method /><comment /></metabolite><metabolite><id>1213</id><name>L-Carnitine</name><specimen>blood</specimen><value>normal decreased</value><min>10.00</min><max>44.00</max><unit>&#181;mol/l</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>1141</id><name>L-Carnitine</name><specimen>plasma</specimen><value>normal decreased</value><min>13.00</min><max>23.00</max><unit>&#181;mol/l</unit><age>infant</age><method /><comment /></metabolite><metabolite><id>1142</id><name>L-Carnitine</name><specimen>plasma</specimen><value>normal decreased</value><min>11.50</min><max>18.00</max><unit>&#181;mol/l</unit><age>1-7 years</age><method /><comment /></metabolite><metabolite><id>1143</id><name>L-Carnitine</name><specimen>plasma</specimen><value>normal decreased</value><min>18.00</min><max>30.00</max><unit>&#181;mol/l</unit><age>7-15 years</age><method /><comment /></metabolite><metabolite><id>267</id><name>L-Carnitine</name><specimen>plasma</specimen><value>normal decreased</value><min>40.00</min><max>60.00</max><unit>&#181;mol/l</unit><age>child</age><method /><comment /></metabolite><metabolite><id>1089</id><name>L-Carnitine</name><specimen>plasma</specimen><value>normal decreased</value><min>9.00</min><max>23.00</max><unit>&#181;mol/l</unit><age>premature</age><method /><comment /></metabolite><metabolite><id>694</id><name>Creatine kinase</name><specimen>serum</specimen><value>increased</value><min>40.00</min><max>400.00</max><unit>U/l</unit><age>child</age><method /><comment /></metabolite><metabolite><id>309</id><name>Creatine kinase</name><specimen>serum</specimen><value>increased</value><min>40.00</min><max>150.00</max><unit>U/l</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>308</id><name>Creatine kinase</name><specimen>serum</specimen><value>increased</value><min>60.00</min><max>400.00</max><unit>U/l</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>947</id><name>Creatine kinase</name><specimen>serum</specimen><value>increased</value><min>25.00</min><max>90.00</max><unit>U/l</unit><age>adult</age><method /><comment /></metabolite><metabolite><id>1885</id><name>D-Glucose</name><specimen>urine</specimen><value>increased</value><min>12.50</min><max>58.40</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>NMR</method><comment>The Human Urine Metabolome</comment></metabolite><metabolite><id>495</id><name>Dicarboxylic acids</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>0.00</max><unit>traces</unit><age>child</age><method /><comment /></metabolite><metabolite><id>1121</id><name>Dicarboxylic acids</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>0.00</max><unit>traces</unit><age>infancy</age><method /><comment /></metabolite><metabolite><id>1413</id><name>D-Glucose</name><specimen>urine</specimen><value>increased</value><min>100.00</min><max>209.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method /><comment>day 1-7</comment></metabolite><metabolite><id>1609</id><name>D-Glucose</name><specimen>urine</specimen><value>increased</value><min>12.50</min><max>58.40</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>NMR</method><comment>The Human Urine Metabolome</comment></metabolite><metabolite><id>1844</id><name>D-Glucose</name><specimen>urine</specimen><value>increased</value><min>76.00</min><max>810.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment /></metabolite><metabolite><id>47</id><name>D-Glucose</name><specimen>plasma</specimen><value>increased</value><min>2.60</min><max>5.50</max><unit>mmol/l</unit><age>Adolescence</age><method /><comment>fasted</comment></metabolite><metabolite><id>281</id><name>D-Glucose</name><specimen>plasma</specimen><value>increased</value><min>2.60</min><max>5.50</max><unit>mmol/l</unit><age>Adulthood</age><method /><comment>fasted</comment></metabolite><metabolite><id>282</id><name>D-Glucose</name><specimen>plasma</specimen><value>increased</value><min>3.30</min><max>5.50</max><unit>mmol/l</unit><age>Childhood</age><method /><comment>fasted</comment></metabolite><metabolite><id>280</id><name>D-Glucose</name><specimen>plasma</specimen><value>increased</value><min>1.10</min><max>3.30</max><unit>mmol/l</unit><age>premature</age><method /><comment /></metabolite><metabolite><id>283</id><name>D-Glucose</name><specimen>plasma</specimen><value>increased</value><min>2.20</min><max>3.30</max><unit>mmol/l</unit><age>Neonatal</age><method /><comment>fasted, 1 day</comment></metabolite><metabolite><id>46</id><name>D-Glucose</name><specimen>plasma</specimen><value>increased</value><min>2.80</min><max>5.00</max><unit>mmol/l</unit><age>Neonatal</age><method /><comment>fasted, &gt;1 day</comment></metabolite><metabolite><id>399</id><name>D-Glucose</name><specimen>cerebrospinal fluid</specimen><value>increased</value><min>1.70</min><max>3.70</max><unit>mmol/l</unit><age>Childhood</age><method /><comment /></metabolite><metabolite><id>1134</id><name>D-Glucose</name><specimen>plasma</specimen><value>increased</value><min>2.70</min><max>4.50</max><unit>mmol/l</unit><age /><method /><comment /></metabolite><metabolite><id>1135</id><name>D-Glucose</name><specimen>plasma</specimen><value>increased</value><min>3.00</min><max>4.30</max><unit>mmol/l</unit><age /><method /><comment /></metabolite><metabolite><id>490</id><name>D-Glucose</name><specimen>blood</specimen><value>normal/dec</value><min>2.60</min><max>5.50</max><unit>mmol/l</unit><age>Childhood</age><method /><comment /></metabolite><metabolite><id>333</id><name>D-Glucose</name><specimen>blood</specimen><value>normal/dec</value><min>2.60</min><max>5.50</max><unit>mmol/l</unit><age>Neonatal</age><method /><comment /></metabolite><metabolite><id>334</id><name>D-Glucose</name><specimen>blood</specimen><value>normal/dec</value><min>2.60</min><max>5.50</max><unit>mmol/l</unit><age>Infancy</age><method /><comment /></metabolite><metabolite><id>1251</id><name>Hexadecenoylcarnitine (C16:1)</name><specimen>blood</specimen><value>normal/dec</value><min>0.04</min><max>0.47</max><unit>&#181;mol/l</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>1252</id><name>Hexadecenoylcarnitine (C16:1)</name><specimen>serum</specimen><value>normal/dec</value><min>0.07</min><max>0.80</max><unit>&#181;mol/l</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>475</id><name>Ketone bodies (urine)</name><specimen>urine</specimen><value>normal/inc</value><min>    </min><max>    </max><unit>negative</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>2025</id><name>L-Carnitine</name><specimen>urine</specimen><value>normal/inc</value><min>0.00</min><max>0.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment>Bruker 2018</comment></metabolite><metabolite><id>1259</id><name>Linoleoylcarnitine (C18:2)</name><specimen>blood</specimen><value>normal/inc</value><min>0.06</min><max>0.59</max><unit>&#181;mol/l</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>1260</id><name>Linoleoylcarnitine (C18:2)</name><specimen>serum</specimen><value>normal/inc</value><min>0.10</min><max>1.00</max><unit>&#181;mol/l</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>1113</id><name>Long chain acyl carnitines</name><specimen>urine</specimen><value>normal/inc</value><min>0.00</min><max>0.00</max><unit>mmol/mol creatinine</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>82</id><name>Long chain acyl carnitines</name><specimen>plasma</specimen><value>increased</value><min>0.00</min><max>7.00</max><unit>&#181;mol/l</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>1117</id><name>Long chain acyl carnitines</name><specimen>tissues</specimen><value>increased</value><min>    </min><max>    </max><unit>no data</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>1261</id><name>Oleoylcarnitine (C18:1)</name><specimen>blood</specimen><value>increased</value><min>0.73</min><max>3.15</max><unit>&#181;mol/l</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>1262</id><name>Oleoylcarnitine (C18:1)</name><specimen>serum</specimen><value>increased</value><min>1.24</min><max>5.36</max><unit>&#181;mol/l</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>1253</id><name>Palmitoylcarnitine (C16)</name><specimen>blood</specimen><value>increased</value><min>1.53</min><max>8.63</max><unit>&#181;mol/l</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>1254</id><name>Palmitoylcarnitine (C16)</name><specimen>serum</specimen><value>increased</value><min>2.60</min><max>14.67</max><unit>&#181;mol/l</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>793</id><name>pH</name><specimen>urine</specimen><value>increased</value><min>6.00</min><max>7.00</max><unit>no unit</unit><age>infancy</age><method /><comment /></metabolite><metabolite><id>60</id><name>pH</name><specimen>blood</specimen><value>decreased</value><min>7.35</min><max>7.45</max><unit>no unit</unit><age>child</age><method /><comment /></metabolite><metabolite><id>302</id><name>pH</name><specimen>blood</specimen><value>decreased</value><min>7.20</min><max>7.40</max><unit>no unit</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>303</id><name>pH</name><specimen>blood</specimen><value>decreased</value><min>7.10</min><max>7.30</max><unit>no unit</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>301</id><name>pH</name><specimen>blood</specimen><value>decreased</value><min>7.30</min><max>7.50</max><unit>no unit</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>300</id><name>pH</name><specimen>blood</specimen><value>decreased</value><min>7.10</min><max>7.40</max><unit>no unit</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>1686</id><name>Sebacic acid</name><specimen>urine</specimen><value>normal/inc</value><min>0.00</min><max>2.00</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>NMR</method><comment>The Human Urine Metabolome</comment></metabolite><metabolite><id>2037</id><name>Sebacic acid</name><specimen>urine</specimen><value>normal/inc</value><min>0.00</min><max>0.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment>Bruker 2018</comment></metabolite><metabolite><id>1378</id><name>Sebacic acid</name><specimen>urine</specimen><value>normal/inc</value><min>0.00</min><max>57.00</max><unit>mmol/mol creatinine</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>95</id><name>Sebacic acid</name><specimen>urine</specimen><value>normal/inc</value><min>0.00</min><max>2.00</max><unit>mmol/mol creatinine</unit><age>child</age><method /><comment /></metabolite><metabolite><id>94</id><name>Suberic acid</name><specimen>urine</specimen><value>normal/inc</value><min>1.00</min><max>10.00</max><unit>mmol/mol creatinine</unit><age>Childhood</age><method /><comment /></metabolite><metabolite><id>650</id><name>Suberic acid</name><specimen>urine</specimen><value>normal/inc</value><min>3.00</min><max>14.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method /><comment /></metabolite><metabolite><id>651</id><name>Suberic acid</name><specimen>urine</specimen><value>normal/inc</value><min>2.00</min><max>15.00</max><unit>mmol/mol creatinine</unit><age>Infancy</age><method /><comment /></metabolite><metabolite><id>653</id><name>Suberic acid</name><specimen>urine</specimen><value>normal/inc</value><min>1.00</min><max>7.00</max><unit>mmol/mol creatinine</unit><age>childhood 6-12y</age><method /><comment /></metabolite><metabolite><id>654</id><name>Suberic acid</name><specimen>urine</specimen><value>normal/inc</value><min>1.00</min><max>6.00</max><unit>mmol/mol creatinine</unit><age>Adolescence</age><method /><comment /></metabolite><metabolite><id>2039</id><name>Suberic acid</name><specimen>urine</specimen><value>normal/inc</value><min>0.00</min><max>0.00</max><unit>mmol/g creatinine</unit><age>Neonatal</age><method>NMR</method><comment>Bruker 2018</comment></metabolite><metabolite><id>378</id><name>Suberic acid</name><specimen>cerebrospinal fluid</specimen><value>normal/inc</value><min>0.00</min><max>1.70</max><unit>&#956;mol/l</unit><age>child</age><method /><comment /></metabolite><metabolite><id>379</id><name>Suberic acid</name><specimen>plasma</specimen><value>normal/inc</value><min>0.00</min><max>10.00</max><unit>&#181;mol/l</unit><age>child</age><method /><comment /></metabolite><metabolite><id>652</id><name>Suberic acid</name><specimen>urine</specimen><value>normal/inc</value><min>0.00</min><max>10.10</max><unit>mmol/mol creatinine</unit><age>child</age><method /><comment /></metabolite><metabolite><id>1239</id><name>Tetradecadienoylcarnitine (C14:2)</name><specimen>blood</specimen><value>increased</value><min>0.00</min><max>0.12</max><unit>&#181;mol/l</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>1240</id><name>Tetradecadienoylcarnitine (C14:2)</name><specimen>serum</specimen><value>increased</value><min>0.01</min><max>0.20</max><unit>&#181;mol/l</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>1243</id><name>Tetradecanoylcarnitine (C14)/Propionylcarnitine (C3)</name><specimen>blood</specimen><value>increased</value><min>0.08</min><max>0.43</max><unit>&#181;mol/ml</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>1244</id><name>Tetradecanoylcarnitine (C14)/Propionylcarnitine (C3)</name><specimen>serum</specimen><value>increased</value><min>0.14</min><max>0.73</max><unit>&#181;mol/ml</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>1166</id><name>Tetradecenoic acid</name><specimen>plasma</specimen><value>increased</value><min>    </min><max>    </max><unit>no data</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>1241</id><name>Tetradecenoylcarnitine (C14:1)</name><specimen>blood</specimen><value>increased</value><min>0.02</min><max>0.27</max><unit>&#181;mol/l</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>1242</id><name>Tetradecenoylcarnitine (C14:1)</name><specimen>serum</specimen><value>increased</value><min>0.03</min><max>0.46</max><unit>&#181;mol/l</unit><age>newborn</age><method /><comment /></metabolite></Metabolites><Literatures><literature><id>7331</id><title>Nutritional ketosis improves exercise metabolism in patients with very long-chain acyl-CoA dehydrogenase deficiency</title><author>Bleeker JC,</author><journal>J Inherit Metab Dis</journal><year>2020</year><book /><volume>0</volume><number>0</number><pages /><co_aut>et al.</co_aut></literature><literature><id>8126</id><title>Effects of Triheptanoin (UX007) in Patients with Long-chain Fatty Acid Oxidation Disorders (LC-FAOD): Results from an Open-Labe</title><author>Vockley J,</author><journal>J Inherit Metab Dis</journal><year>2020</year><book /><volume>0</volume><number>0</number><pages /><co_aut>et al.</co_aut></literature><literature><id>6789</id><title>AAV9 gene replacement therapy for respiratory insufficiency in very-long chain acyl-CoA dehydrogenase deficiency</title><author>Zieger M,</author><journal>J Inherit Metab Dis</journal><year>2019</year><book /><volume>0</volume><number>0</number><pages /><co_aut>et al.</co_aut></literature><literature><id>6803</id><title>Very Long-Chain Acyl-Coenzyme A Dehydrogenase Deficiency</title><author>Leslie ND,</author><journal>GeneReviews&#174; [Internet]</journal><year>2019</year><book /><volume>0</volume><number>0</number><pages /><co_aut>et al.</co_aut></literature><literature><id>6979</id><title>Clinical and biochemical outcome of patients with very long-chain acyl-CoA dehydrogenase deficiency</title><author>Rovelli V,</author><journal>Mol Genet Metab</journal><year>2019</year><book /><volume>127</volume><number>1</number><pages>64-73</pages><co_aut>et al.</co_aut></literature><literature><id>8125</id><title>Results from a 78-week, single-arm, open-label phase 2 study to evaluate UX007 in pediatric and adult patients with severe long-chain fatty acid oxidation disorders (LC-FAO</title><author>Vockley J,</author><journal>J Inherit Metab Dis</journal><year>2019</year><book /><volume>42</volume><number>1</number><pages>169-177</pages><co_aut>et al.</co_aut></literature><literature><id>6357</id><title>The diagnostic challenge in very-long chain acyl-CoA dehydrogenase deficiency (VLCADD)</title><author>Hesse J,</author><journal>J Inherit Metab Dis</journal><year>2018</year><book /><volume>0</volume><number>0</number><pages /><co_aut>et al.</co_aut></literature><literature><id>4108</id><title>Triheptanoin: long-term effects in the very long-chain acyl-CoA dehydrogenase-deficient mouse</title><author>Tucci S,</author><journal>J Lipid Res</journal><year>2017</year><book /><volume>58</volume><number>1</number><pages>196-207</pages><co_aut>et al.</co_aut></literature><literature><id>4131</id><title>Fibroblast Fatty-Acid Oxidation Flux Assays Stratify Risk in Newborns with Presumptive-Positive Results on S</title><author>Olpin SE,</author><journal>Int J Neonatal Screen</journal><year>2017</year><book /><volume>3</volume><number>2</number><pages /><co_aut>et al.</co_aut></literature><literature><id>5028</id><title>Four Years Experience in the Diagnosis of Very Long-Chain Acyl-CoA Dehydrogenase Deficiency in Infants Detected in Three Spanis</title><author>Merinero B,</author><journal>JIMD Rep</journal><year>2017</year><book /><volume>0</volume><number>0</number><pages /><co_aut>et al.</co_aut></literature><literature><id>5029</id><title>Very long-chain acyl-CoA dehydrogenase (VLCAD-) deficiency-studies on treatment effects and long-term outcomes in mouse models&lt;</title><author>Tucci S</author><journal>J Inherit Metab Dis</journal><year>2017</year><book /><volume>40</volume><number>3</number><pages>317-323</pages><co_aut /></literature><literature><id>4109</id><title>Cardiac failure in very long chain acyl-CoA dehydrogenase deficiency requiring extracorporeal membrane oxygenation (ECMO) treat</title><author>Katz S,</author><journal>Mol Genet Metab Rep</journal><year>2016</year><book /><volume>10</volume><number>0</number><pages>5-7</pages><co_aut>et al.</co_aut></literature><literature><id>4110</id><title>VLCAD deficiency: Follow-up and outcome of patients diagnosed through newborn screening in Victoria</title><author>Evans M,</author><journal>Mol Genet Metab</journal><year>2016</year><book /><volume>118</volume><number>4</number><pages>282-287</pages><co_aut>et al.</co_aut></literature><literature><id>4111</id><title>Outcomes and genotype-phenotype correlations in 52 individuals with VLCAD deficiency diagnosed by NBS and enrolled in the IBEM-</title><author>Pena LD,</author><journal>Mol Genet Metab</journal><year>2016</year><book /><volume>118</volume><number>4</number><pages>272-281</pages><co_aut>et al.</co_aut></literature><literature><id>4133</id><title>Elevations of C14:1 and C14:2 Plasma Acylcarnitines in Fasted Children: A Diagnostic Dilemma</title><author>Burrage LC,</author><journal>J Pediatr</journal><year>2016</year><book /><volume>169</volume><number>0</number><pages>208-213</pages><co_aut>et al.</co_aut></literature><literature><id>4112</id><title>Strategies for correcting very long chain acyl-CoA dehydrogenase deficiency</title><author>Tenopoulou M,</author><journal>J Biol Chem</journal><year>2015</year><book /><volume>290</volume><number>16</number><pages>10486-94</pages><co_aut>et al.</co_aut></literature><literature><id>4113</id><title>Anesthetic agents in patients with very long-chain acyl-coenzyme A dehydrogenase deficiency: a literature review</title><author>Redshaw C,</author><journal>Paediatr Anaesth</journal><year>2014</year><book /><volume>24</volume><number>11</number><pages>1115-1119</pages><co_aut>Stewart C</co_aut></literature><literature><id>4132</id><title>Infants suspected to have very-long chain acyl-CoA dehydrogenase deficiency from newborn screening</title><author>Merritt JL 2nd,</author><journal>Mol Genet Metab</journal><year>2014</year><book /><volume>111</volume><number>4</number><pages>484-492</pages><co_aut>et al.</co_aut></literature><literature><id>4114</id><title>Early presentation of very long chain acyl-CoA dehydrogenase deficiency: nursing action resulting in a positive outcome</title><author>Sedgwick ER</author><journal>J Pediatr Nurs</journal><year>2013</year><book /><volume>28</volume><number>4</number><pages>379-382</pages><co_aut /></literature><literature><id>4115</id><title>Very Long-Chain Acyl-Coenzyme A Dehydrogenase Deficiency</title><author>Leslie ND,</author><journal>GeneReviews&#174; [Internet]</journal><year>2009</year><book>GeneReviews&#174; [Internet]</book><volume>0</volume><number>0</number><pages /><co_aut>et al.</co_aut></literature><literature><id>2767</id><title>Development of a new enzymatic diagnosis method for very-long-chain acyl-CoA dehydrogenase deficiency by detecting 2-hexadeceno</title><author>Tajima G</author><journal>Pediatr Res</journal><year>2008</year><book /><volume>0</volume><number>0</number><pages /><co_aut>et al.</co_aut></literature><literature><id>2768</id><title>PPARs as therapeutic targets for correction of inborn mitochondrial fatty acid oxidation disorders.</title><author>Djouadi F</author><journal>J Inherit Metab Dis</journal><year>2008</year><book /><volume>0</volume><number>0</number><pages /><co_aut>Bastin J</co_aut></literature><literature><id>2770</id><title>Genetic basis for correction of very-long-chain acyl-coenzyme A dehydrogenase deficiency by bezafibrate in patient fibroblasts:</title><author>Gobin-Limballe S</author><journal>Am J Hum Genet</journal><year>2007</year><book /><volume>81</volume><number>6</number><pages>1133-1143</pages><co_aut>et al.</co_aut></literature><literature><id>2769</id><title>Bezafibrate increases very-long-chain acyl-CoA dehydrogenase protein and mRNA expression in deficient fibroblasts and is a pote</title><author>Djouadi F</author><journal>Hum Mol Genet</journal><year>2005</year><book /><volume>14</volume><number>18</number><pages>2695-2703</pages><co_aut>et al.</co_aut></literature><literature><id>1932</id><title>A new diagnostic test for VLCAD deficiency using immunohistochemistry</title><author>Ohashi Y</author><journal>Neurology</journal><year>2004</year><book /><volume>62</volume><number>0</number><pages>2209-2213</pages><co_aut>et al.</co_aut></literature><literature><id>8216</id><title>[Very-long-chain acyl-CoA dehydrogenase deficiency presenting with recurrent rhabdomyolysis in an adult]</title><author>Hamano H,</author><journal>Rinsho Shinkeigaku</journal><year>2003</year><book /><volume>43</volume><number>5</number><pages>53-257</pages><co_aut>et al.</co_aut></literature><literature><id>1184</id><title>Diagnosis of very long chain acyl-dehydrogenase deficiency from an infants newborn screening card</title><author>Wood JC</author><journal>Pediatrics 2001 Jul;108(1):E19</journal><year>2001</year><book /><volume>108</volume><number>0</number><pages>E19</pages><co_aut>et al.</co_aut></literature><literature><id>1933</id><title>Myopathic form of very-long chain acyl-coa dehydrogenase deficiency: evidence for temperature-sensitive mild mutations in both </title><author>Fukao T</author><journal>Pediatr Res</journal><year>2001</year><book /><volume>49</volume><number>2</number><pages>227-231</pages><co_aut>et al.</co_aut></literature><literature><id>980</id><title>Molecular heterogeneity in very-long-chain acyl-CoA dehydrogenase deficiency causing pediatric cardiomyopathy and sudden death&lt;</title><author>Mathur A</author><journal>Circulation</journal><year>1999</year><book /><volume>99</volume><number>10</number><pages>1337-1343</pages><co_aut>et al.</co_aut></literature><literature><id>891</id><title>Retrospective biochemical screening of fatty acid oxidation disorders in postmortem livers of 418 cases of sudden death in the f</title><author>Boles RG</author><journal>J Pediatr</journal><year>1998</year><book /><volume>132</volume><number>6</number><pages>924-933</pages><co_aut>et al.</co_aut></literature><literature><id>908</id><title>Very long chain acyl-CoA dehydrogenase deficiency with adult onset</title><author>Smelt AH</author><journal>Ann Neurol</journal><year>1998</year><book /><volume>43</volume><number>4</number><pages>540-544</pages><co_aut>et al.</co_aut></literature><literature><id>909</id><title>Reversal of severe hypertrophic cardiomayopathy and excellent neuropsychologic outcome in very-long-chain acyl-coenzyme A dehydr</title><author>Cox GF</author><journal>J Pediatr</journal><year>1998</year><book /><volume>133</volume><number>0</number><pages>247-253</pages><co_aut>et al.</co_aut></literature><literature><id>918</id><title>The effect of fasting, long-chain triglyceride load and carnitine load on plasma long-chain acyl-carnitine levels in mitochondri</title><author>Costa CG</author><journal>J Inherit Metab Dis</journal><year>1998</year><book /><volume>21</volume><number>0</number><pages>391-399</pages><co_aut>et al.</co_aut></literature><literature><id>920</id><title>Mitochondrial very-long-chain acyl-coenzyme A dehydrogenase deficiency: clinical characteristics and diagnostic considerations i</title><author>Vianey-Saban C</author><journal>Clin Chim Acta</journal><year>1998</year><book /><volume>269</volume><number>0</number><pages>43-62</pages><co_aut>et al.</co_aut></literature><literature><id>929</id><title>Acute, severe cardiomyopathy as main symptom of late-onset very long-chain acyl-coenzyme A dehydrogenase deficiency</title><author>Parini R</author><journal>Eur J Pediatr</journal><year>1998</year><book /><volume>157</volume><number>0</number><pages>992-995</pages><co_aut>et al.</co_aut></literature><literature><id>898</id><title>Very long chain acyl-coenzyme A dehydrogenase deficiency in two siblings: evolution after prenatal diagnosis and prompt manageme</title><author>Sluysmans T</author><journal>J Pediatr</journal><year>1997</year><book /><volume>131</volume><number>0</number><pages>444-446</pages><co_aut>et al.</co_aut></literature><literature><id>919</id><title>Recurrent myoglobinuria as a presenting manifestation of very long chain acyl coenzyme A dehydrogenase deficiency</title><author>Straussberg R</author><journal>Pediatrics</journal><year>1997</year><book /><volume>99</volume><number>0</number><pages>894-896</pages><co_aut>et al.</co_aut></literature><literature><id>701</id><title>Cloning and characterization of human very-long-chain acyl-CoA dehydrogenase cDNA, chromosomal assignment of the gene and identi</title><author>Andresen BS</author><journal>Hum Mol Genet</journal><year>1996</year><book /><volume>5</volume><number>4</number><pages>461-472</pages><co_aut>et al.</co_aut></literature><literature><id>702</id><title>Mutation analysis of very-long.chain acyl-coenzyme A dehydrogenase (VLACD) deficiency: identification and characterization of mi</title><author>Souri M</author><journal>Am J Hum Genet</journal><year>1996</year><book /><volume>58</volume><number>4</number><pages>97-106</pages><co_aut>et al.</co_aut></literature><literature><id>703</id><title>Very long chain acyl-CoA dehydrogenase deficiency: successful treatment of acute cardiomyopathy</title><author>Brown-Harrison MC</author><journal>Biochem Mol Med</journal><year>1996</year><book /><volume>58</volume><number>0</number><pages>59-65</pages><co_aut>et al.</co_aut></literature><literature><id>704</id><title>Molecular basis of human mitochondrial very-long-chain acyl-CoA dehydrogenase deficiency causing cardiomyopathy and sudden death</title><author>Strauss AW</author><journal>Proc Natl Acad Sci USA</journal><year>1995</year><book /><volume>92</volume><number>0</number><pages>10496-500</pages><co_aut>et al.</co_aut></literature><literature><id>705</id><title>Purification of human very-long-chain acyl-coenzyme A dehydrogenase and chracterization of its deficiency in seven patients</title><author>Aoyama T</author><journal>J Clin Invest</journal><year>1995</year><book /><volume>95</volume><number>6</number><pages>2465-73</pages><co_aut>et al.</co_aut></literature><literature><id>706</id><title>Identification and quantification of intermediates of unsaturated fatty acid metabolism in plasma of patients with fatty acid ox</title><author>Onkenhout W</author><journal>Clin Chem</journal><year>1995</year><book /><volume>41</volume><number>0</number><pages>1467-1474</pages><co_aut>et al.</co_aut></literature><literature><id>930</id><title>Very long-chain acyl coenzyme A dehydrogenase deficiency presenting with exercise-induced myoglobinuria</title><author>Ogilvie I</author><journal>Neurology</journal><year>1994</year><book /><volume>44</volume><number>0</number><pages>467-473</pages><co_aut>et al.</co_aut></literature><literature><id>709</id><title>Very long chain acyl-CoA dehydrogenase deficiency: identification of a new inborn error of mitochondrial fatty acid oxidation in</title><author>Bertrand C</author><journal>Biochem Biophys Acta</journal><year>1993</year><book /><volume>1180</volume><number>0</number><pages>327-329</pages><co_aut>et al.</co_aut></literature><literature><id>710</id><title>Identification of very-long-chain acyl-CoA dehydrogenase deficiency in three patients previously diagnosed with long-chain acyl-</title><author>Yamagucchi S</author><journal>Pediatr Res</journal><year>1993</year><book /><volume>34</volume><number>0</number><pages>111-113</pages><co_aut>et al.</co_aut></literature><literature><id>5031</id><title>A simple spectrophotometric assay for long-chain acyl-CoA dehydrogenase activity measurements in human skin fibroblasts</title><author>Ijlst L,</author><journal>Ann Clin Biochem</journal><year>1993</year><book /><volume>30</volume><number>3</number><pages>293-297</pages><co_aut>Wanders RJ</co_aut></literature></Literatures></Disease>